CONTACTAbout UsCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Equal Entertainment LLC.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
The government's chief of AIDS research rewrote a safety report on a U.S.-funded study of the anti-HIV drug nevirapine, sold in the United States as Viramune, to change its conclusions and delete negative information. Later he ordered research on the drug resumed over the objections of his staff, documents show. Edmund Tramont, chief of the National Institutes of Health's AIDS Division, took responsibility for both decisions. He cited his four decades of medical experience and argued that Africans in the midst of an AIDS crisis deserved some leniency in meeting U.S. safety standards, according to interviews and documents obtained by the Associated Press. The AP reported Monday that the NIH knew about problems related to a Uganda study of using nevirapine to prevent HIV transmissions from HIV-positive pregnant women to their infants, including record-keeping problems, violations of federal patient safety safeguards, and other issues that forced a 15-month halt to the research. NIH officials acknowledge Tramont rewrote a key safety report on nevirapine and overruled his staff, but said he did so because he was more experienced and had an "honest difference of opinion" with his safety experts. They noted he had no financial interest in nevirapine and that the troubled study began well before he joined NIH in 2001. Lane said an internal NIH review concluded Tramont had not engaged in scientific misconduct. Tramont admits to changing a report written by one of his medical officers that summarized safety concerns during a review of the Uganda studies. The report, finished in January 2003, said the Uganda trial suffered from "incomplete or inadequate safety reporting" and that records on patients were "of poor quality and below expected standards of clinical research." The lead researcher strongly urged NIH not to make sweeping conclusions about nevirapine based on the Uganda research. "Safety conclusions from this trial should be very conservative," she wrote. But Tramont says he changed the report and altered its conclusion to say that the study "has demonstrated the safety of single dose nevirapine for the prevention of maternal to child transmission," Tramont's version concluded. "Although discrepancies were found in the database and some unreported AEs [adverse reactions] were discovered...these were not clinically important in determining the safety profile." (AP)
From our Sponsors
Most Popular
31 Period Films of Lesbians and Bi Women in Love That Will Take You Back
December 09 2024 1:00 PM
18 of the most batsh*t things N.C. Republican governor candidate Mark Robinson has said
October 30 2024 11:06 AM
True
These 15 major companies caved to the far right and stopped DEI programs
January 24 2025 1:11 PM
True
Latest Stories
S.C. attorney general tells state's capital city to drop its conversion therapy ban
April 26 2025 10:08 AM
Holy labor pains! How one woman (allegedly) became the first female pope
April 26 2025 6:00 AM
Before Pete Buttigieg pandered to bros, he should have checked in with Billy Eichner
April 26 2025 6:00 AM
Pedro Pascal says transphobe J.K. Rowling is 'heinous loser'
April 25 2025 6:29 PM
Fox News anchor appears to use antigay slur in rant about Pete Buttigieg
April 25 2025 3:56 PM
Houston's Black Queer AF Week promises music, visibility, hope, and joy
April 25 2025 1:18 PM
George Santos sentenced to prison
April 25 2025 12:06 PM
People in states with abortion bans are twice as likely to die during pregnancy
April 25 2025 10:32 AM
Hidden Sapphic gems: Discover these 20 overlooked lesbian movies
April 25 2025 10:24 AM
Visions of Solidarity: Lesbian writers on how we save the world from fascism
April 25 2025 7:49 AM
Makeup, lights, camera, and action! Pete Hegseth stars in ‘Defenseless Secretary’
April 25 2025 6:00 AM
University of Louisville caves to anti-LGBTQ+ forces twice this week
April 24 2025 6:45 PM
Must-see LGBTQ+ films every straight ally should watch
April 24 2025 4:37 PM
Defense Department reinstates gender-affirming care for trans troops
April 24 2025 4:25 PM
Meta Oversight Board rules anti-transgender videos don't violate hate speech rules
April 24 2025 12:42 PM